Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
![]() |
fig.3.A.n,o
Pfirrmann T et al. (2015) |
Xla Wt + rmnd5a MO
NF35/36-35 and 36 (in situ hybridization) |
|
|||||
![]() |
fig.3.A.n,o,q
Pfirrmann T et al. (2015) |
Xla Wt + rmnd5a MO
NF35/36-35 and 36 (in situ hybridization) |
|
|||||
![]() |
fig.3.A.q
Pfirrmann T et al. (2015) |
Xla Wt + rmnd5a MO
NF35/36-35 and 36 (in situ hybridization) |
|
|||||
![]() |
fig.S4.b
Walentek P et al. (2012) |
Xla Wt + atp4a MO
NF26 (in situ hybridization) |
|
|||||
![]() |
fig.5.c
Belyaeva OV et al. (2012) |
Xla Wt + sdr16c5
NF32-32 (in situ hybridization) |
||||||
![]() |
Fig 3.A
Koebernick K et al. (2006) |
Xla Wt + tshz1
NF14-16 (in situ hybridization) |
|
|||||
![]() |
Fig 3.B
Koebernick K et al. (2006) |
Xla Wt + tshz1 MO
NF14-16 (in situ hybridization) |
|
|||||
![]() |
Fig.2.k
Fredieu JR et al. (1997) |
Xla Wt + LiCl
NF29/30 (in situ hybridization) |
|
|||||
![]() |
Fig.2.o
Fredieu JR et al. (1997) |
Xla Wt + LiCl
NF29/30 (in situ hybridization) |
|
|||||
![]() |
Fig.2.s
Fredieu JR et al. (1997) |
Xla Wt + LiCl
NF29/30 (in situ hybridization) |
|